From 2002 to 2013, the mean price of insulin increased 197 percent, from $4.34 per milliliter to $12.92 per milliliter, according to a survey of more than 27,000 people treated for diabetes.

The Centers for Medicare and Medicaid Services (CMS) have proposed banning Theranos founder Elizabeth Holmes and president Sunny Balwani from owning or running a blood-testing lab for at least two years.

After the U.S. Department of Treasury issued temporary and proposed regulations on tax inversions and other related topics, Medtronic announced in a news release on April 6 that the regulations “do not have a material financial impact on any transaction undertaken by the company.”

Medtronic announced a cash tender offer on March 31 for up to $2.75 billion in aggregate purchase price for outstanding debt issued by Medtronic, Inc. and Covidien International Finance S.A., two of the company’s wholly-owned subsidiaries.

Edwards Lifesciences Corp. announced that Steven R. Loranger had been appointed to its board of directors.

By 2022, the global market for lower extremity stents, percutaneous transluminal angioplasty (PTA) balloons, PTA drug-eluting balloons, carotid stents, renal stents and other peripheral vascular interventions will increase to $3.4 billion, up from $2.1 billion last year.

A Florida businessman was sentenced to more than 14 years in prison for his role in a healthcare fraud and money laundering scheme, according to a Department of Justice (DOJ) news release.

A microsimulation cardiovascular disease risk prediction model found that a 10 percent subsidy on the price of fruits and vegetables would lead to reductions in cardiovascular disease deaths, non-fatal MI and non-fatal stroke.